Gene Delivery
Partnership
Approach
About
News
Blog
Menu
Close
Dyno Therapeutics Unveils In Vivo Genetic Payload Screening Service and Lambda-1 Capsid World Model, Expanding AI-Powered Gene Delivery Tools at GATC 2026
Press
November 18, 2026
businesswire
TOC LINK
TOC LINK
Press
Published
November 18, 2026
More like this
Dyno Therapeutics Unveils In Vivo Genetic Payload Screening Service and Lambda-1 Capsid World Model, Expanding AI-Powered Gene Delivery Tools at GATC 2026
Press
businesswire
November 18, 2026
Dyno Therapeutics Unveils In Vivo Genetic Payload Screening Service and Lambda-1 Capsid World Model, Expanding AI-Powered Gene Delivery Tools at GATC 2026
Press
businesswire
November 18, 2026
Dyno Therapeutics Expands Frontiers Network with Multiple Global Options to Accelerate Path to Clinical Proof of Concept at GATC 2026
Press
businesswire
November 18, 2026
Dyno Therapeutics Expands Frontiers Network with Multiple Global Options to Accelerate Path to Clinical Proof of Concept at GATC 2026
Press
businesswire
November 18, 2026
Dyno Therapeutics Unveils In Vivo Genetic Payload Screening Service and Lambda-1 Capsid World Model, Expanding AI-Powered Gene Delivery Tools at GATC 2026
Announcements
Dyno Therapeutics
November 18, 2026
Dyno Therapeutics Unveils In Vivo Genetic Payload Screening Service and Lambda-1 Capsid World Model, Expanding AI-Powered Gene Delivery Tools at GATC 2026
Announcements
Dyno Therapeutics
November 18, 2026
Dyno Therapeutics Expands Frontiers Network with Multiple Global Options to Accelerate Path to Clinical Proof of Concept at GATC 2026
Announcements
Dyno Therapeutics
November 18, 2026
Dyno Therapeutics Expands Frontiers Network with Multiple Global Options to Accelerate Path to Clinical Proof of Concept at GATC 2026
Announcements
Dyno Therapeutics
November 18, 2026
343 Arsenal St
Watertown, MA 02472
© Dyno 2026
Privacy Policy
Terms + Conditions
Dyno Therapeutics, DYNO, the DYNO logo, and mountain design are registered trademarks of Dyno Therapeutics, Inc. All rights reserved.